Cellectar Biosciences Names Cameron Szakacs VP, Clinical Development

(RTTNews) - Cellectar Biosciences, Inc. (CLRB) Tuesday said it has appointed Cameron Szakacs as vice president of clinical development.

Szakacs has over 18 years of leadership and experience in the pharmaceutical industry, including expertise in strategy, design and execution of global clinical programs in oncology and orphan indications.

In this newly created position, Szakacs will report to president and chief executive officer Simon Pedder and will be responsible for guiding Cellectar's clinical programs.

In connection with the commencement of his employment, Szakacs was granted, as an inducement award, an option to purchase 50,000 shares of Cellectar common stock.